Carl Llor Selected Research

Bronchitis

2/2022	Efficacy and safety of discontinuing antibiotic treatment for uncomplicated respiratory tract infections when deemed unnecessary. A multicentre, randomized clinical trial in primary care.
1/2019	Effectiveness of antitussives, anticholinergics or honey versus usual care in adults with uncomplicated acute bronchitis: a study protocol of an open randomised clinical trial in primary care.
1/2017	The STOP-AB trial protocol: efficacy and safety of discontinuing patient antibiotic treatment when physicians no longer consider it necessary.
1/2016	Antibiotic prescribing for acute bronchitis.
10/2014	Is C-reactive protein testing useful to predict outcome in patients with acute bronchitis?
12/2013	Marked differences in GPs' diagnosis of pneumonia between Denmark and Spain: a cross-sectional study.
10/2013	Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial.
6/2011	Effectiveness of anti-inflammatory treatment versus antibiotic therapy and placebo for patients with non-complicated acute bronchitis with purulent sputum. The BAAP Study protocol.
5/2009	The sale of antibiotics without prescription in pharmacies in Catalonia, Spain.
9/2004	Spanish primary healthcare physicians' knowledge of resistance of respiratory germs and antimicrobial treatment in acute bronchitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl Llor Research Topics

Disease

28	Respiratory Tract Infections (Respiratory Tract Infection) 02/2022 - 11/2006
21	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2005
13	Pharyngitis (Sore Throat) 02/2022 - 05/2009
11	Infections 11/2021 - 10/2006
10	Bronchitis 02/2022 - 09/2004
10	Cough 12/2019 - 06/2011
6	Pneumonia (Pneumonitis) 01/2022 - 04/2013
5	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 05/2009
4	Rhinosinusitis 02/2022 - 12/2012
4	Virus Diseases (Viral Diseases) 01/2017 - 11/2006
4	Fever (Fevers) 06/2013 - 09/2004
3	COVID-19 05/2022 - 01/2020
3	Human Influenza (Influenza) 02/2022 - 01/2017
3	Hypersensitivity (Allergy) 01/2019 - 05/2009
2	Chronic Bronchitis 08/2015 - 11/2013
2	Pneumococcal Infections 04/2013 - 09/2004
1	Cystitis 01/2022
1	Obesity 01/2022
1	Respiratory Sounds (Crackle) 01/2021
1	Heart Failure 01/2021
1	Vomiting 01/2020
1	Nausea 01/2020
1	Lung Diseases (Lung Disease) 01/2019
1	Communicable Diseases (Infectious Diseases) 12/2018
1	Streptococcal Infections (Streptococcal Infection) 05/2014
1	Common Cold 11/2013
1	Nasal Polyps (Nasal Polyp) 06/2013
1	Bacterial Infections (Bacterial Infection) 04/2010
1	Pneumococcal Pneumonia 10/2006

Drug/Important Bio-Agent (IBA)

70	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 09/2004
20	C-Reactive ProteinIBA 01/2022 - 12/2010
5	Amoxicillin (Wymox)FDA LinkGeneric 01/2019 - 01/2009
5	AntigensIBA 01/2017 - 03/2010
4	Penicillins (Penicillin)FDA Link 01/2019 - 09/2004
3	Penicillin V (Phenoxymethylpenicillin)FDA LinkGeneric 10/2020 - 04/2013
3	MacrolidesIBA 10/2020 - 09/2004
3	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2013 - 01/2009
2	Antitussive Agents (Antitussives)FDA Link 01/2019 - 01/2017
1	Sulfamethizole (Thiosulfil)FDA Link 01/2022
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2022
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2022
1	Fosfomycin FDA Link 11/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 10/2020
1	Oxygen (Dioxygen)IBA 03/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Oseltamivir (Tamiflu)FDA Link 01/2020
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 01/2019
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2019
1	Expectorants (Mucolytics)IBA 01/2017
1	Bronchodilator Agents (Bronchodilators)IBA 01/2017
1	Nasal Decongestants (Decongestants)IBA 01/2017
1	GoldIBA 01/2017
1	Ibuprofen (Motrin)FDA LinkGeneric 10/2013
1	Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link 10/2013
1	Pharmaceutical PreparationsIBA 05/2009
1	QuinolonesIBA 02/2009
1	beta-LactamsIBA 02/2009
1	Polysaccharides (Glycans)IBA 10/2006
1	VaccinesIBA 10/2006
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 10/2006
1	Anti-Infective Agents (Microbicides)IBA 09/2004

Therapy/Procedure

10	Therapeutics 02/2022 - 09/2004
1	Contraindications 01/2019
1	Nebulizers and Vaporizers (Inhaler) 01/2019
1	Length of Stay 12/2014
1	Duration of Therapy 05/2009